Who owns Arizona Knee Signal?

What does that business tie mean for you?

This isn't an outside review of the clinics or their care. People who own QC Kinetix clinics in the Phoenix area also own this site, and a booking may bring them business. That interest matters when you read the clinic list. The ownership notice appears plainly on every page.

Ownership doesn't move those QC Kinetix clinics higher in the Arizona list. Public ratings, review counts, dates, and distance are handled the same way for each office. That check limits the owners' influence on the order. It doesn't remove their interest in your booking.

The list can give you clinic names and public comments. It can't tell why your knee is sore or which care fits. Reviews may cover courtesy, bills, or waiting rather than a knee result. An exam and your full health history matter more.

Ratings, addresses, office hours, and services can change. Open the public page and call before traveling. Ask who examines the knee, what care is offered, the full cost, and who answers later questions. If an answer isn't plain, wait before deciding.

We don't collect patient accounts or turn comments into praise. We also don't choose your care. This site gives general facts, not personal medical or legal advice. Sudden severe soreness, strong swelling, redness, warmth, or a fever should be seen promptly.

Evidence sources

1. The FTC's Health Products Compliance Guidance requires that health-benefit claims be supported by competent and reliable scientific evidence - generally randomized, controlled human clinical testing - and holds advertisers responsible for both express and implied claims, including implied claims of efficacy carried by testimonials.

   U.S. Federal Trade Commission — Health Products Compliance Guidance. U.S. Federal Trade Commission, 2022.

2. FDA's HCT/P guidance sets out the minimal-manipulation and homologous-use criteria that decide whether a human cell or tissue product is regulated solely under 21 CFR Part 1271 (section 361) or requires a biologics licence; cell-based orthopaedic injections that fall outside those criteria are unapproved drugs and biological products, and no cell-based product is FDA-approved to treat osteoarthritis.

   U.S. Food and Drug Administration — Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use - Guidance for Industry and FDA Staff. U.S. Food and Drug Administration, 2020.